Cargando…
Simvastatin-Loaded Nanostructured Lipid Carriers as Topical Drug Delivery System for Wound Healing Purposes: Preparation, Characterization, and In Vivo Histopathological Studies
PURPOSE: Simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, is a commonly used drug to reduce total cholesterol and low-density lipoprotein (LDL) levels. Furthermore, several mechanisms showed the wound-healing potential of statins, especially simvastatin. Simvastati...
Autores principales: | Mousavi-Simakani, Seyedeh Maryam, Azadi, Amir, Tanideh, Nader, Omidifar, Navid, Ghasemiyeh, Parisa, Mohammadi-Samani, Soliman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676542/ https://www.ncbi.nlm.nih.gov/pubmed/38022815 http://dx.doi.org/10.34172/apb.2023.083 |
Ejemplares similares
-
Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages
por: Ghasemiyeh, Parisa, et al.
Publicado: (2018) -
Artemether-loaded nanostructured lipid carriers: preparation, characterization, and evaluation of in vitro effect on Leishmania major
por: Rahnama, Vahid, et al.
Publicado: (2021) -
Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages
por: Ghasemiyeh, Parisa, et al.
Publicado: (2020) -
COVID-19 outbreak: Challenges in pharmacotherapy based on pharmacokinetic and pharmacodynamic aspects of drug therapy in patients with moderate to severe infection
por: Ghasemiyeh, Parisa, et al.
Publicado: (2020) -
The necessity of early anti-inflammatory therapy initiation in cases with mild-to-moderate COVID-19: A personal experience from an attending pharmacist and his resident
por: Parisa, Ghasemiyeh, et al.
Publicado: (2021)